ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
出版年份 2019 全文链接
标题
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 29, Issue 4, Pages 728-760
出版商
BMJ
发表日期
2019-05-03
DOI
10.1136/ijgc-2019-000308
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Editorial
- (2018) C Fotopoulou et al. ANNALS OF ONCOLOGY
- Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
- (2018) Lydia Giannopoulou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer
- (2018) Roberto Tozzi et al. GYNECOLOGIC ONCOLOGY
- Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type
- (2018) Sebastien Gouy et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Trial of Optimal Personalised Care After Treatment—Gynaecological Cancer (TOPCAT-G)
- (2018) Val Morrison et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
- (2018) Helena M. Ditzel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
- (2018) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic indicators in ovarian serous borderline tumours
- (2018) Anais Malpica et al. PATHOLOGY
- Endometriosis-associated ovarian neoplasia
- (2018) Xavier Matias-Guiu et al. PATHOLOGY
- A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study.
- (2018) Robert L. Coleman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.
- (2018) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- 933OCarboplatin/pegylated liposomal doxorubicin/bevacizumab (CD-BEV) vs. carboplatin/gemcitabine/bevacizumab (CG-BEV) in patients with recurrent ovarian cancer: A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO study group, AGO-Austria, ANZGOG, GINECO, SGCTG)
- (2018) J Pfisterer et al. ANNALS OF ONCOLOGY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- (2017) Katrijn Michielsen et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial
- (2017) Roman Rouzier et al. EUROPEAN JOURNAL OF CANCER
- Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer
- (2017) Florence Joly et al. EUROPEAN JOURNAL OF CANCER
- Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study
- (2017) Lino M. Sawicki et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice
- (2017) Christina Fotopoulou et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
- (2017) Giuseppe Scaletta et al. Expert Review of Anticancer Therapy
- Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors
- (2017) Kobe Dewilde et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
- (2017) Heather J. Dalton et al. GYNECOLOGIC ONCOLOGY
- FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper
- (2017) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis
- (2017) Aoshuang Cheng et al. GYNECOLOGIC ONCOLOGY
- Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
- (2017) Amanda N. Fader et al. GYNECOLOGIC ONCOLOGY
- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
- (2017) Ritu Salani et al. GYNECOLOGIC ONCOLOGY
- Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
- (2017) Amit M. Oza et al. GYNECOLOGIC ONCOLOGY
- High-grade serous carcinoma of tubo-ovarian origin: recent developments
- (2017) Naveena Singh et al. HISTOPATHOLOGY
- The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma
- (2017) Priya Singh et al. HISTOPATHOLOGY
- Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al
- (2017) Philipp Harter et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma
- (2017) Edwina Coghlan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
- (2017) Denis Querleu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Cancer Follow-up
- (2017) Anne Lanceley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma
- (2017) W. Glenn McCluggage et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
- (2017) Ethan Basch et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
- (2017) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
- (2017) Jung-Yun Lee et al. Journal of Gynecologic Oncology
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
- (2017) Robert L Coleman et al. LANCET ONCOLOGY
- Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging
- (2017) Naveena Singh et al. MODERN PATHOLOGY
- Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer
- (2017) Allison Gockley et al. OBSTETRICS AND GYNECOLOGY
- Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study
- (2017) Felicia T. Roncolato et al. ONCOLOGIST
- Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer
- (2017) Madeleine T. King et al. QUALITY OF LIFE RESEARCH
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
- (2017) Saeed Rafii et al. Oncotarget
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
- (2016) Dirk Timmerman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy
- (2016) Eun Ji Han et al. ANNALS OF NUCLEAR MEDICINE
- Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
- (2016) K. Lindemann et al. ANNALS OF ONCOLOGY
- Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues
- (2016) E. Bentivegna et al. ANNALS OF ONCOLOGY
- Patient-reported outcomes (PRO) in ovarian cancer clinical trials—lost opportunities and lessons learned: Table 1.
- (2016) M. Friedlander et al. ANNALS OF ONCOLOGY
- Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities
- (2016) Christina Fotopoulou et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
- (2016) Katrijn L M Michielsen et al. BRITISH JOURNAL OF RADIOLOGY
- Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
- (2016) Bradley J. Monk et al. CURRENT PHARMACEUTICAL DESIGN
- A phase III trial of bevacizumab with IV versus IP chemotherapy for ovarian, fallopian tube, and peritoneal carcinoma: An NRG Oncology Study
- (2016) J. Walker et al. GYNECOLOGIC ONCOLOGY
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- (2016) Jacek P. Grabowski et al. GYNECOLOGIC ONCOLOGY
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group trials
- (2016) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
- (2016) Susan M. Domchek et al. GYNECOLOGIC ONCOLOGY
- Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT)
- (2016) Nikoline Marie Schou Karlsen et al. GYNECOLOGIC ONCOLOGY
- Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer
- (2016) Alexander Hotouras et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
- (2016) Peter G. Rose et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer
- (2016) György Sölétormos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
- (2016) Denis Querleu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma
- (2016) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer
- (2016) Sudeshna Chatterjee et al. OBSTETRICS AND GYNECOLOGY
- Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
- (2016) Steffen Hauptmann et al. VIRCHOWS ARCHIV
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
- (2016) Neil Lineberry et al. BMJ-British Medical Journal
- Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
- (2016) Neil Lineberry et al. BMJ-British Medical Journal
- Incidental Serous Tubal Intraepithelial Carcinoma and Early Invasive Serous Carcinoma in the Nonprophylactic Setting
- (2015) Jane C. Morrison et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
- (2015) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
- (2015) K. S. Tewari et al. ANNALS OF ONCOLOGY
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- New Pointers for Surgical Staging of Borderline Ovarian Tumors
- (2015) Sofiane Bendifallah et al. ANNALS OF SURGICAL ONCOLOGY
- What Should We Expect After a Complete Cytoreduction at the Time of Interval or Primary Debulking Surgery in Advanced Ovarian Cancer?
- (2015) Luis Chiva et al. ANNALS OF SURGICAL ONCOLOGY
- Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013
- (2015) Jaime Prat BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer
- (2015) J J You et al. BRITISH JOURNAL OF CANCER
- Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors
- (2015) Ines Vasconcelos et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients
- (2015) Enrica Bentivegna et al. FERTILITY AND STERILITY
- The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
- (2015) Erin K. Crane et al. GYNECOLOGIC ONCOLOGY
- A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
- (2015) Luis M. Chiva et al. GYNECOLOGIC ONCOLOGY
- Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group
- (2015) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum
- (2015) Naveena Singh et al. HISTOPATHOLOGY
- Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
- (2015) Steffen Böhm et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
- (2015) Rosalind A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
- (2015) Andres M. Poveda et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2015) Devansu Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance and Care of the Gynecologic Cancer Survivor
- (2015) Stephanie S. Faubion et al. JOURNAL OF WOMENS HEALTH
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
- (2015) W Glenn McCluggage et al. MODERN PATHOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- A Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants
- (2015) I. Vasconcelos et al. ONCOLOGIST
- The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters
- (2015) Naveena Singh et al. PATHOLOGY
- General practitioners’ attitudes toward follow-up after cancer treatment: A cross-sectional questionnaire study
- (2015) Heidi Lidal Fidjeland et al. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
- Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
- (2015) Xingang Peng et al. World Journal of Surgical Oncology
- Ultrasound in Gynecological Cancer: Is It Time for Re-evaluation of Its Uses?
- (2015) Daniela Fischerova et al. Current Oncology Reports
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery
- (2014) Joseph T. Rabban et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments
- (2014) C. Uzan et al. ANNALS OF ONCOLOGY
- Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
- (2014) F. Trillsch et al. ANNALS OF ONCOLOGY
- Optimal treatment of early-stage ovarian cancer
- (2014) F. Collinson et al. ANNALS OF ONCOLOGY
- The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer
- (2014) A. Backen et al. CLINICAL CANCER RESEARCH
- Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer
- (2014) M.E.L. van der Burg et al. EUROPEAN JOURNAL OF CANCER
- The role of palliative colorectal stents in gynaecologic malignancy
- (2014) Leah Jutzi et al. GYNECOLOGIC ONCOLOGY
- Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
- (2014) Rachel N. Grisham et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Low-Grade Serous Tumors of Ovary
- (2014) Debra A. Bell INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Primary Ovarian Mucinous Adenocarcinoma of Intestinal Type
- (2014) Surapan Khunamornpong et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
- (2014) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2014) Robert A. Burger et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture
- (2014) Dai Shimizu et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
- (2014) Sandro Pignata et al. LANCET ONCOLOGY
- Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis
- (2013) Hyun Jong Park et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary
- (2013) C. Uzan et al. ANNALS OF ONCOLOGY
- Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
- (2013) I. Bajrami et al. CANCER RESEARCH
- Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
- (2013) F. Collinson et al. CLINICAL CANCER RESEARCH
- Predictive Biomarkers for Bevacizumab: Are We There Yet?
- (2013) D. Maru et al. CLINICAL CANCER RESEARCH
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- Bowel obstruction in recurrent gynecologic malignancies: Defining who will benefit from surgical intervention
- (2013) T. Perri et al. EJSO
- Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group
- (2013) Andreas du Bois et al. EUROPEAN JOURNAL OF CANCER
- Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases
- (2013) K. Muyldermans et al. EUROPEAN JOURNAL OF CANCER
- Outcome differences in patients with advanced epithelial ovarian, primary peritoneal and fallopian tube cancers treated with and without bevacizumab
- (2013) L. Randall et al. GYNECOLOGIC ONCOLOGY
- Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants
- (2013) Alexandra Leary et al. GYNECOLOGIC ONCOLOGY
- A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age
- (2013) Hiroaki Kajiyama et al. International Journal of Clinical Oncology
- Salvage Surgery Due To Bowel Obstruction in Advanced or Relapsed Ovarian Cancer Resulting in Short Bowel Syndrome and Long-Life Total Parenteral Nutrition
- (2013) Christina Fotopoulou et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
- (2013) Xiaoxiang Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Survival in Women With Grade 1 Serous Ovarian Carcinoma
- (2013) Amanda Nickles Fader et al. OBSTETRICS AND GYNECOLOGY
- Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
- (2012) R. Fruscio et al. ANNALS OF ONCOLOGY
- Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation
- (2012) Christina Fotopoulou et al. ANNALS OF SURGICAL ONCOLOGY
- Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome
- (2012) Nour Sneige et al. CANCER CYTOPATHOLOGY
- Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
- (2012) S. Mahner et al. EUROPEAN JOURNAL OF CANCER
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
- (2012) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer
- (2012) Rebecca Byler Dann et al. GYNECOLOGIC ONCOLOGY
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
- (2012) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options
- (2012) Emile Daraï et al. HUMAN REPRODUCTION UPDATE
- Impact of Routine Follow-Up Examinations on Life Expectancy in Ovarian Cancer Patients
- (2012) Sandra M. E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary
- (2012) Toshio Takada et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma
- (2012) Mika Mizuno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
- (2012) Philippe Morice et al. LANCET ONCOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Behavior of Serous Borderline Ovarian Tumors With and Without Micropapillary Patterns: Results of a French Multicenter Study
- (2011) R. Fauvet et al. ANNALS OF SURGICAL ONCOLOGY
- Low-grade serous primary peritoneal carcinoma
- (2011) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study
- (2011) Robert S. Mannel et al. GYNECOLOGIC ONCOLOGY
- Accuracy of frozen section diagnosis of ovarian borderline tumor
- (2011) K.K. Shih et al. GYNECOLOGIC ONCOLOGY
- Micropapillary pattern in serous borderline ovarian tumors: Does it matter?
- (2011) Jeong-Yeol Park et al. GYNECOLOGIC ONCOLOGY
- Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical staging
- (2011) Cecelia A. Powless et al. GYNECOLOGIC ONCOLOGY
- No Supportive Evidence for Clinical Benefit of Routine Follow-Up in Ovarian Cancer
- (2011) Sandra M.E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Considering Early Detection of Relapsed Ovarian Cancer
- (2011) Sandra M.E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Fertility-Sparing Surgery for Borderline Ovarian Tumors
- (2011) Taejong Song et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer
- (2011) Philipp Harter et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Surgical and Medical Treatment of Clear Cell Ovarian Cancer
- (2011) Francescapaola Magazzino et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer
- (2011) Gavin C.E. Stuart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin
- (2011) T. Safra et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer
- (2010) J. A. Ledermann et al. CLINICAL CANCER RESEARCH
- Understanding the problem of inadequately staging early ovarian cancer
- (2010) P.J. Timmers et al. EUROPEAN JOURNAL OF CANCER
- Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary
- (2010) Aminata Kane et al. FERTILITY AND STERILITY
- The role of restaging borderline ovarian tumors: Single institution experience and review of the literature
- (2010) Ignacio Zapardiel et al. GYNECOLOGIC ONCOLOGY
- Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up
- (2010) S. Palomba et al. HUMAN REPRODUCTION
- Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?
- (2010) Jamie N. Bakkum-Gamez et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
- (2010) Ali Dastranj Tabrizi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection
- (2010) Toyomi Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial
- (2010) B. Trimbos et al. JNCI-Journal of the National Cancer Institute
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary
- (2009) C. Uzan et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy
- (2009) Jean-Luc Brun et al. BMC CANCER
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers
- (2009) Chunqiao Tian et al. CANCER
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
- (2009) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Prognostic Factors in Patients with Ovarian Serous Low Malignant Potential (Borderline) Tumors with Peritoneal Implants
- (2009) A. Kane et al. ONCOLOGIST
- Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
- (2008) J D Wright et al. BRITISH JOURNAL OF CANCER
- Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
- (2008) Nilofer S. Azad et al. CANCER
- CA 125, PET alone, PET–CT, CT and MRI in diagnosing recurrent ovarian carcinoma
- (2008) Ping Gu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective study
- (2007) S. Risum et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started